Trades on 2 secondary markets

Vilya

Vilya is a computational drug-design biotechnology company pioneering the de novo design of macrocycles — entirely new therapeutic molecules that do not exist in nature. Spun out of the Institute for Protein Design and built on Nobel Prize-winning computational protein-design research from scientifi

emerging 15.0 / 100 0 APIs View provider profile →

Company Biotechnology Drug Discovery Artificial Intelligence Computational Biology Macrocycles

Vilya is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.